STOCK TITAN

Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Zomedica, a veterinary health company specializing in point-of-care diagnostics and therapeutic products for equine and companion animals, will present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024.

The event will include a webcasted presentation at 10:15 am ET, accessible via the conference website or directly at https://wsw.com/webcast/lytham11/zom/1950102. The presentation will also be available for replay.

Additionally, Zomedica's management will hold virtual one-on-one meetings with investors throughout the day. Interested parties can schedule meetings by contacting Lytham Partners or registering for the event.

Positive
  • Zomedica's participation in the Lytham Partners Spring 2024 Investor Conference increases visibility among investors.
  • The webcasted presentation provides a platform to present recent developments and future plans to a broad audience.
  • One-on-one meetings offer direct communication with potential and current investors, fostering stronger relationships.
Negative
  • The press release lacks specific financial updates or new clinical data, which might disappoint investors looking for concrete progress or results.
  • No mention of significant product launches or partnerships, which could be seen as a lack of major developments.

ANN ARBOR, MI / ACCESSWIRE / May 21, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

Company Webcast

The webcasted presentation will take place at 10:15am ET on Thursday, May 30, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2024/ or directly at https://wsw.com/webcast/lytham11/zom/1950102. The webcast will also be available for replay following the event.

1×1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/spring2024invreg/.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.zomedica.com.

Follow Zomedica

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on accesswire.com

FAQ

What date and time will Zomedica present at the Lytham Partners Spring 2024 Investor Conference?

Zomedica will present at 10:15 am ET on May 30, 2024.

How can investors access Zomedica's presentation at the Lytham Partners Spring 2024 Investor Conference?

Investors can access the presentation via the conference website or directly at https://wsw.com/webcast/lytham11/zom/1950102.

Can the presentation be viewed after the live event?

Yes, the presentation will be available for replay following the event.

How can investors arrange one-on-one meetings with Zomedica's management during the conference?

Interested parties can arrange meetings by contacting Lytham Partners at 1×1@lythampartners.com or registering for the event at https://lythampartners.com/spring2024invreg/.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

129.35M
949.95M
1.78%
8.33%
5.12%
Medical Devices
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR